Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glaucoma: Overview01:25

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
Open Angle Glaucoma: Treatment01:27

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment01:28

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
Accessory Structures of the Eye01:17

Accessory Structures of the Eye

Optical perception, or vision, is an extraordinary sense dependent on converting light signals received via the ocular organs. These organs, known as eyes, are securely positioned within the bony cavities of the skull, called orbits. The orbits serve a dual purpose: a protective shield for the ocular globes and a stable attachment point for the soft ocular tissues. The eye's external protective mechanisms include the eyelids, which are edged with lashes that act as a barrier against foreign...
Increased Intracranial Pressure ll: Pathophysiology01:29

Increased Intracranial Pressure ll: Pathophysiology

Increased intracranial pressure (ICP) refers to a potentially life-threatening rise in pressure inside the skull. This usually happens when there is a major change in the volume of brain tissue, blood, or cerebrospinal fluid (CSF) — the three components inside the skull. According to the Monro-Kellie doctrine, if the volume of one component increases, the volumes of the other components must decrease to maintain normal pressure. If this does not happen, ICP rises.The process often begins with...
Muscles of the Eye01:20

Muscles of the Eye

The muscles of the eye are sophisticated structures that control eye movement and focus, allowing for the precise and rapid adjustments necessary for vision. The human eye is controlled by ten muscles — six extraocular muscles, three intraocular muscles, and one primary eyelid retractor muscle.
Extraocular Muscles
The six extraocular muscles surround the eyeball and control its movements. They are responsible for a wide range of eye motions, including looking up, down, left, right, and rotating...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cutaneous silent period in patients with obstructive sleep apnea.

Sleep & breathing = Schlaf & Atmung·2026
Same author

Comment on "Variations in clinical features and disease burden of myasthenia gravis between racial and ethnic groups: A retrospective cohort study of two national databases".

Journal of the neurological sciences·2026
Same author

Melatonin and oxidative DNA damage in REM- and NREM-related obstructive sleep apnea: an exploratory analysis of sleep-stage phenotypes.

European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·2026
Same author

Transcranial doppler-derived cerebrovascular resistance changes during vagus nerve stimulation in drug-resistant epilepsy.

Epilepsy research·2026
Same author

Comment on "Immune checkpoint inhibitors-related overlap syndrome: can a second course of intravenous immunoglobulin help?"

Acta neurologica Belgica·2026
Same author

Immune checkpoint inhibitor rechallenge after severe neurological immune-related adverse events: Timing and immunomodulatory context.

Journal of neuroimmunology·2026

Related Experiment Video

Updated: Jun 23, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Ophthalmoplegic migraine.

Semai Bek1, Gencer Genc, Seref Demirkaya

  • 1Gulhane Medical Faculty, Department of Neurology, Etlik, Ankara, Turkey. semaibek@yahoo.com

The Neurologist
|May 12, 2009
PubMed
Summary
This summary is machine-generated.

Ophthalmoplegic migraine, a condition involving headache and ocular nerve palsy, may stem from demyelination. This case study shows successful treatment with methylprednisolone, resolving symptoms and MRI findings.

More Related Videos

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Minimally Invasive Surgical Decompression of Occipital Nerves
04:06

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

Related Experiment Videos

Last Updated: Jun 23, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
10:39

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache

Published on: June 2, 2014

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents
10:10

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Minimally Invasive Surgical Decompression of Occipital Nerves
04:06

Minimally Invasive Surgical Decompression of Occipital Nerves

Published on: September 13, 2024

Area of Science:

  • Neurology
  • Ophthalmology

Background:

  • Ophthalmoplegic migraine (OM) is characterized by recurrent headaches with migrainous features and cranial nerve palsies, typically affecting the third nerve.
  • The International Headache Society defines OM in the absence of intracranial lesions, with recent reclassification suggesting a demyelinating etiology over microvascular causes.

Observation:

  • A 21-year-old male presented with recurrent right frontal headaches, ptosis, and right eye adduction paralysis.
  • Clinical symptoms, including eyelid drooping and double vision, persisted for approximately 3 months.
  • Brain MRI revealed thickening and enhancement of the right oculomotor nerve.

Findings:

  • Treatment with intravenous methylprednisolone resulted in clinical improvement within two weeks.
  • Resolution of oculomotor nerve enhancement on MRI was observed three months post-treatment.
  • This case provides pre- and post-treatment documentation of oculomotor nerve thickening in ophthalmoplegic migraine.

Implications:

  • The findings support the reclassification of ophthalmoplegic migraine as a demyelinating condition.
  • Methylprednisolone may be an effective treatment for ophthalmoplegic migraine with oculomotor nerve involvement.
  • This case highlights the importance of neuroimaging and prompt treatment in managing ophthalmoplegic migraine.